Cover Image
市場調查報告書

NanoBio Corporation的產品平台分析

NanoBio Corporation - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 204922
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
NanoBio Corporation的產品平台分析 NanoBio Corporation - Product Pipeline Review - 2015
出版日期: 2015年07月22日 內容資訊: 英文 29 Pages
簡介

NanoBio Corporation是開發及商品化傳染病的預防/治療用疫苗之生物醫藥品企業。

本報告提供NanoBio Corporation的產品開發平台現狀及各開發階段比較分析,提供您藥物簡介,開發平台分析與最新趨勢,以及暫停中的計劃等資訊。

NanoBio Corporation的基本資料

NanoBio Corporation概要

  • 主要資訊
  • 企業資料

NanoBio Corporation:R&D概要

  • 主要的治療範圍

NanoBio Corporation:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

NanoBio Corporation:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

NanoBio Corporation:藥物簡介

  • 炭疽疫苗
  • 2形式單純皰疹病毒疫苗
  • HIV疫苗
  • H5N1流感疫苗
  • NB-401
  • 呼吸道融合病毒(RSV)疫苗
  • 百日咳疫苗

NanoBio Corporation:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

NanoBio Corporation:最近的開發平台趨勢

NanoBio Corporation:暫停中的計劃

NanoBio Corporation:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07274CDB

Summary

Global Markets Direct's, 'NanoBio Corporation - Product Pipeline Review - 2015', provides an overview of the NanoBio Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of NanoBio Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of NanoBio Corporation including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of NanoBio Corporation's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the NanoBio Corporation's pipeline products

Reasons to buy

  • Evaluate NanoBio Corporation's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of NanoBio Corporation in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the NanoBio Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of NanoBio Corporation and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of NanoBio Corporation
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of NanoBio Corporation and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • NanoBio Corporation Snapshot
    • NanoBio Corporation Overview
    • Key Information
    • Key Facts
  • NanoBio Corporation - Research and Development Overview
    • Key Therapeutic Areas
  • NanoBio Corporation - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • NanoBio Corporation - Pipeline Products Glance
    • NanoBio Corporation - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • NanoBio Corporation - Drug Profiles
    • anthrax vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • herpes simplex virus [type 2] vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HIV vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • influenza [strain H5N1] vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NB-401
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • respiratory syncytial virus vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • pertussis vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • NanoBio Corporation - Pipeline Analysis
    • NanoBio Corporation - Pipeline Products by Target
    • NanoBio Corporation - Pipeline Products by Route of Administration
    • NanoBio Corporation - Pipeline Products by Molecule Type
    • NanoBio Corporation - Pipeline Products by Mechanism of Action
  • NanoBio Corporation - Recent Pipeline Updates
  • NanoBio Corporation - Dormant Projects
  • NanoBio Corporation - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • NanoBio Corporation, Key Information
  • NanoBio Corporation, Key Facts
  • NanoBio Corporation - Pipeline by Indication, 2015
  • NanoBio Corporation - Pipeline by Stage of Development, 2015
  • NanoBio Corporation - Monotherapy Products in Pipeline, 2015
  • NanoBio Corporation - Partnered Products in Pipeline, 2015
  • NanoBio Corporation - Partnered Products/ Combination Treatment Modalities, 2015
  • NanoBio Corporation - Preclinical, 2015
  • NanoBio Corporation - Discovery, 2015
  • NanoBio Corporation - Pipeline by Target, 2015
  • NanoBio Corporation - Pipeline by Route of Administration, 2015
  • NanoBio Corporation - Pipeline by Molecule Type, 2015
  • NanoBio Corporation - Pipeline Products by Mechanism of Action, 2015
  • NanoBio Corporation - Recent Pipeline Updates, 2015
  • NanoBio Corporation - Dormant Developmental Projects,2015

List of Figures

  • NanoBio Corporation - Pipeline by Top 10 Indication, 2015
  • NanoBio Corporation - Pipeline by Stage of Development, 2015
  • NanoBio Corporation - Monotherapy Products in Pipeline, 2015
  • NanoBio Corporation - Partnered Products in Pipeline, 2015
  • NanoBio Corporation - Pipeline by Top 10 Route of Administration, 2015
  • NanoBio Corporation - Pipeline by Top 10 Molecule Type, 2015
Back to Top